J&J's Cash Challenge, Gilead's Life After HCV, Pfizer's Pricing Gripe

 
• By Lucie Ellis-Taitt

Held in Boston, Sept. 7-8, the Wells Fargo Healthcare Conference saw the likes of Gilead Sciences, Johnson and Johnson and Pfizer discuss their strategies for 2017, pipeline highlights and biggest challenges. We pick out five key pointers from industry leaders.

Business men on a Chess board
J&J, Gilead and Pfizer share strategy tips at Wells Fargo investment meeting • Source: Shutterstock/hin255

More from Strategy

More from Business